Oren Malkin

PulseCath BV develops, manufactures and markets circulatory support systems. It offers iVAC 3L, a mid-range minimal heart circulatory assist device that generates up to three liters per minute, and offers critical hemodynamic support in the case of left ventricular failure or during high-risk revascularization procedures with potential post craniotomy weaning complications. The company was founded in 2007 and is headquartered in Arnhem, Germany.

PulseCath BV develops, manufactures and markets circulatory support systems. It offers iVAC 3L, a mid-range minimal heart circulatory assist device that generates up to three liters per minute, and offers critical hemodynamic support in the case of left ventricular failure or during high-risk revascularization procedures with potential post craniotomy weaning complications. The company was founded in 2007 and is headquartered in Arnhem, Germany.

PulseCath BV develops, manufactures and markets circulatory support systems. It offers iVAC 3L, a mid-range minimal heart circulatory assist device that generates up to three liters per minute, and offers critical hemodynamic support in the case of left ventricular failure or during high-risk revascularization procedures with potential post craniotomy weaning complications. The company was founded in 2007 and is headquartered in Arnhem, Germany.

PulseCath BV develops, manufactures and markets circulatory support systems. It offers iVAC 3L, a mid-range minimal heart circulatory assist device that generates up to three liters per minute, and offers critical hemodynamic support in the case of left ventricular failure or during high-risk revascularization procedures with potential post craniotomy weaning complications. The company was founded in 2007 and is headquartered in Arnhem, Germany.